Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Peter

Showing results (651-660 of 674) with videos related to

Pageof 68
Sort By:
JAMA Oncology|September 4, 2020
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical TrialKohei Shitara, Eric Van Cutsem, Yung-Jue Bang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2020
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal CancerTakashi Kojima, Manish A Shah, Kei Muro, et al.
The New England Journal of Medicine|June 4, 2013
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanomaOmid Hamid, Caroline Robert, Adil Daud, et al.
Muscle & Nerve|February 29, 2020
Conference report on contractures in musculoskeletal and neurological conditionsGlen H Nuckolls, Kathi Kinnett, Sudarshan Dayanidhi, et al.
Science Immunology|April 7, 2023
Computational prediction of MHC anchor locations guides neoantigen identification and prioritizationHuiming Xia, Joshua McMichael, Michelle Becker-Hapak, et al.
JAMA|April 20, 2016
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced MelanomaAntoni Ribas, Omid Hamid, Adil Daud, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Automating neoantigen selection for personalized cancer vaccine designJennie X Yao, Kartik Singhal, Susanna Kiwala, et al.
Journal for Immunotherapy of Cancer|July 24, 2023
Autologous humanized PDX modeling for immuno-oncology recapitulates features of the human tumor microenvironmentMichael Chiorazzi, Jan Martinek, Bradley Krasnick, et al.
Science Advances|June 25, 2020
The clonal evolution of metastatic colorectal cancerHa X Dang, Bradley A Krasnick, Brian S White, et al.
NPJ Precision Oncology|October 19, 2023
High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survivalErik P Storrs, Prathamesh Chati, Abul Usmani, et al.
Pageof 68

Showing results (651-660 of 674) with videos related to

Sort By:
Pageof 68
JAMA Oncology|September 4, 2020
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical TrialKohei Shitara, Eric Van Cutsem, Yung-Jue Bang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2020
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal CancerTakashi Kojima, Manish A Shah, Kei Muro, et al.
The New England Journal of Medicine|June 4, 2013
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanomaOmid Hamid, Caroline Robert, Adil Daud, et al.
Muscle & Nerve|February 29, 2020
Conference report on contractures in musculoskeletal and neurological conditionsGlen H Nuckolls, Kathi Kinnett, Sudarshan Dayanidhi, et al.
Science Immunology|April 7, 2023
Computational prediction of MHC anchor locations guides neoantigen identification and prioritizationHuiming Xia, Joshua McMichael, Michelle Becker-Hapak, et al.
JAMA|April 20, 2016
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced MelanomaAntoni Ribas, Omid Hamid, Adil Daud, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Automating neoantigen selection for personalized cancer vaccine designJennie X Yao, Kartik Singhal, Susanna Kiwala, et al.
Journal for Immunotherapy of Cancer|July 24, 2023
Autologous humanized PDX modeling for immuno-oncology recapitulates features of the human tumor microenvironmentMichael Chiorazzi, Jan Martinek, Bradley Krasnick, et al.
Science Advances|June 25, 2020
The clonal evolution of metastatic colorectal cancerHa X Dang, Bradley A Krasnick, Brian S White, et al.
NPJ Precision Oncology|October 19, 2023
High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survivalErik P Storrs, Prathamesh Chati, Abul Usmani, et al.
Pageof 68